Polyphenol‐Nanoengineered Monocyte Biohybrids for Targeted Cardiac Repair and Immunomodulation
Authors:
- 11 November 2024
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (2) , e2403595
Abstract
Myocardial infarction is one of the leading cause of cardiovascular death worldwide. Invasive interventional procedures and medications are applied to attenuate the attacks associated with ischemic heart disease by reestablishing blood flow and restoring oxygen supply. However, the overactivation of inflammatory responses and unsatisfactory drug delivery efficiency in the infarcted regions prohibit functional improvement. Here, a nanoengineered monocyte (MO)‐based biohybrid system, referred to as CTAs @MOs, for the heart‐targeted delivery of combinational therapeutic agents (CTAs) containing anti‐inflammatory IL‐10 and cardiomyogenic miR‐19a to overcome the limitation of malperfusion within the infarcted myocardium through a polyphenol‐mediated interfacial assembly, is reported. Systemic administration of CTAs@MOs bypasses extensive thoracotomy and intramyocardial administration risks, leading to infarcted heart‐specific accumulation and sustained release of therapeutic agents, enabling immunomodulation of the proinflammatory microenvironment and promoting cardiomyocyte proliferation in sequence. Moreover, CTAs@MOs, which serve as a cellular biohybrid‐based therapy, significantly improve cardiac function as evidenced by enhanced ejection fractions, increased fractional shortening, and diminished infarct sizes. This polyphenol nanoengineered biohybrid system represents a general and potent platform for the efficient treatment of cardiovascular disorders.Keywords
Funding Information
- National Natural Science Foundation of China (81700360, 82270249, 82070324, 22178233, 22208228)
- National Institutes of Health (R35GM147455, R35GM150507)
- State Key Laboratory of Polymer Materials Engineering (sklpme 2020‐03‐01)
This publication has 67 references indexed in Scilit:
- Myocardial‐Targeting Tannic Cerium Nanocatalyst Attenuates Ischemia/Reperfusion InjuryAngewandte Chemie International Edition, 2023
- Nanoparticle‐Laden Macrophages for Tumor‐Tropic Drug DeliveryAdvanced Materials, 2022
- In Vitro Evaluation of the Therapeutic Effects of Dual‐Drug Loaded Spermine‐Acetalated Dextran Nanoparticles Coated with Tannic Acid for Cardiac ApplicationsAdvanced Functional Materials, 2021
- Engineering of Living Cells with Polyphenol‐Functionalized Biologically Active NanocomplexesAdvanced Materials, 2020
- Neutrophils Enable Local and Non‐Invasive Liposome Delivery to Inflamed Skeletal Muscle and Ischemic HeartAdvanced Materials, 2020
- Reparative macrophage transplantation for myocardial repair: a refinement of bone marrow mononuclear cell-based therapyBasic Research in Cardiology, 2019
- Self‐Assembled Metal‐Phenolic Nanoparticles for Enhanced Synergistic Combination Therapy against Colon CancerAdvanced Biosystems, 2018
- Cytoprotective Encapsulation of Individual Jurkat T Cells within Durable TiO2 Shells for T‐Cell TherapyAngewandte Chemie International Edition, 2017
- IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activationBasic Research in Cardiology, 2017
- A fluorescence quenching technique using trypan blue to differentiate between attached and ingested glutaraldehyde-fixed red blood cells in phagocytosing murine macrophagesJournal of Immunological Methods, 1983